(VLTO) Veralto - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US92338C1036
Stock: Water Treatment, Marking, Coding, Packaging, Color
Total Rating 46
Risk 92
Buy Signal -0.54
| Risk 5d forecast | |
|---|---|
| Volatility | 23.9% |
| Relative Tail Risk | -2.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.20 |
| Alpha | -17.75 |
| Character TTM | |
|---|---|
| Beta | 0.673 |
| Beta Downside | 0.373 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.73% |
| CAGR/Max DD | 0.30 |
EPS (Earnings per Share)
Revenue
Description: VLTO Veralto March 06, 2026
Veralto Corporation (VLTO) operates in water analytics, water treatment, marking, coding, and packaging/color solutions globally. The company was founded in 2022 and is headquartered in Waltham, Massachusetts.
The Water Quality (WQ) segment provides instrumentation and treatment technologies for residential, commercial, municipal, and industrial water applications. This segment also offers chemical reagents, services, and software. The global water and wastewater treatment market is a critical infrastructure sector with consistent demand.
The Product Quality & Innovation (PQI) segment focuses on marking and coding for packaged goods, digital asset management software, inline printing, packaging design software, and color management solutions. The packaging industry, a key customer for this segment, is a multi-billion dollar market driven by consumer goods.
Veralto serves diverse industries including municipal utilities, food and beverage, pharmaceuticals, and general industrials. Further research on platforms like ValueRay can provide deeper insights into VLTOs market position and financial health.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 940.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.38 > 1.0 |
| NWC/Revenue: 25.00% < 20% (prev 21.99%; Δ 3.01% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.08b > Net Income 940.0m |
| Net Debt (642.0m) to EBITDA (1.35b): 0.48 < 3 |
| Current Ratio: 1.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (250.5m) vs 12m ago 0.08% < -2% |
| Gross Margin: 59.95% > 18% (prev 0.60%; Δ 5935 % > 0.5%) |
| Asset Turnover: 78.06% > 50% (prev 81.06%; Δ -3.00% > 0%) |
| Interest Coverage Ratio: 13.22 > 6 (EBITDA TTM 1.35b / Interest Expense TTM 96.0m) |
Altman Z'' 4.23
| A: 0.18 (Total Current Assets 3.43b - Total Current Liabilities 2.06b) / Total Assets 7.69b |
| B: 0.23 (Retained Earnings 1.74b / Total Assets 7.69b) |
| C: 0.18 (EBIT TTM 1.27b / Avg Total Assets 7.05b) |
| D: 1.06 (Book Value of Equity 4.85b / Total Liabilities 4.59b) |
| Altman-Z'' Score: 4.23 = AA |
Beneish M -3.04
| DSRI: 1.04 (Receivables 897.0m/812.0m, Revenue 5.50b/5.19b) |
| GMI: 0.99 (GM 59.95% / 59.60%) |
| AQI: 0.88 (AQ_t 0.52 / AQ_t-1 0.59) |
| SGI: 1.06 (Revenue 5.50b / 5.19b) |
| TATA: -0.02 (NI 940.0m - CFO 1.08b) / TA 7.69b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of VLTO shares?
As of March 06, 2026, the stock is trading at USD 95.19 with a total of 2,094,950 shares traded.
Over the past week, the price has changed by -2.89%, over one month by +4.85%, over three months by -6.70% and over the past year by -3.04%.
Over the past week, the price has changed by -2.89%, over one month by +4.85%, over three months by -6.70% and over the past year by -3.04%.
Is VLTO a buy, sell or hold?
Veralto has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy VLTO.
- StrongBuy: 6
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VLTO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 110.1 | 15.7% |
| Analysts Target Price | 110.1 | 15.7% |
VLTO Fundamental Data Overview March 05, 2026
P/E Trailing = 25.4362
P/E Forward = 23.2558
P/S = 4.3153
P/B = 7.7602
P/EG = 3.6228
Revenue TTM = 5.50b USD
EBIT TTM = 1.27b USD
EBITDA TTM = 1.35b USD
Long Term Debt = 1.97b USD (from longTermDebt, last quarter)
Short Term Debt = 700.0m USD (from shortTermDebt, last quarter)
Debt = 2.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 642.0m USD (from netDebt column, last quarter)
Enterprise Value = 24.39b USD (23.75b + Debt 2.67b - CCE 2.03b)
Interest Coverage Ratio = 13.22 (Ebit TTM 1.27b / Interest Expense TTM 96.0m)
EV/FCF = 24.05x (Enterprise Value 24.39b / FCF TTM 1.01b)
FCF Yield = 4.16% (FCF TTM 1.01b / Enterprise Value 24.39b)
FCF Margin = 18.43% (FCF TTM 1.01b / Revenue TTM 5.50b)
Net Margin = 17.08% (Net Income TTM 940.0m / Revenue TTM 5.50b)
Gross Margin = 59.95% ((Revenue TTM 5.50b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 59.31% (prev 60.11%)
Tobins Q-Ratio = 3.17 (Enterprise Value 24.39b / Total Assets 7.69b)
Interest Expense / Debt = 0.75% (Interest Expense 20.0m / Debt 2.67b)
Taxrate = 13.31% (39.0m / 293.0m)
NOPAT = 1.10b (EBIT 1.27b * (1 - 13.31%))
Current Ratio = 1.67 (Total Current Assets 3.43b / Total Current Liabilities 2.06b)
Debt / Equity = 0.86 (Debt 2.67b / totalStockholderEquity, last quarter 3.11b)
Debt / EBITDA = 0.48 (Net Debt 642.0m / EBITDA 1.35b)
Debt / FCF = 0.63 (Net Debt 642.0m / FCF TTM 1.01b)
Total Stockholder Equity = 2.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.33% (Net Income 940.0m / Total Assets 7.69b)
RoE = 34.47% (Net Income TTM 940.0m / Total Stockholder Equity 2.73b)
RoCE = 27.0% (EBIT 1.27b / Capital Employed (Equity 2.73b + L.T.Debt 1.97b))
RoIC = 20.42% (NOPAT 1.10b / Invested Capital 5.39b)
WACC = 7.61% (E(23.75b)/V(26.42b) * Re(8.39%) + D(2.67b)/V(26.42b) * Rd(0.75%) * (1-Tc(0.13)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.83%
[DCF] Terminal Value 79.58% ; FCFF base≈936.4m ; Y1≈937.2m ; Y5≈994.2m
[DCF] Fair Price = 73.79 (EV 18.93b - Net Debt 642.0m = Equity 18.29b / Shares 247.8m; r=7.61% [WACC]; 5y FCF grow -0.46% → 2.90% )
EPS Correlation: 93.89 | EPS CAGR: 11.63% | SUE: 3.79 | # QB: 2
Revenue Correlation: 95.11 | Revenue CAGR: 4.77% | SUE: -0.48 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.02 | Chg7d=+0.001 | Chg30d=-0.012 | Revisions Net=-3 | Analysts=14
EPS current Year (2026-12-31): EPS=4.19 | Chg7d=+0.007 | Chg30d=+0.013 | Revisions Net=+5 | Growth EPS=+7.5% | Growth Revenue=+6.3%
EPS next Year (2027-12-31): EPS=4.55 | Chg7d=+0.003 | Chg30d=+0.001 | Revisions Net=+3 | Growth EPS=+8.6% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -0.33 (3 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.5% (Discount Rate 8.4% - Earnings Yield 3.9%)
[Growth] Growth Spread = +1.8% (Analyst 6.3% - Implied 4.5%)
P/E Forward = 23.2558
P/S = 4.3153
P/B = 7.7602
P/EG = 3.6228
Revenue TTM = 5.50b USD
EBIT TTM = 1.27b USD
EBITDA TTM = 1.35b USD
Long Term Debt = 1.97b USD (from longTermDebt, last quarter)
Short Term Debt = 700.0m USD (from shortTermDebt, last quarter)
Debt = 2.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 642.0m USD (from netDebt column, last quarter)
Enterprise Value = 24.39b USD (23.75b + Debt 2.67b - CCE 2.03b)
Interest Coverage Ratio = 13.22 (Ebit TTM 1.27b / Interest Expense TTM 96.0m)
EV/FCF = 24.05x (Enterprise Value 24.39b / FCF TTM 1.01b)
FCF Yield = 4.16% (FCF TTM 1.01b / Enterprise Value 24.39b)
FCF Margin = 18.43% (FCF TTM 1.01b / Revenue TTM 5.50b)
Net Margin = 17.08% (Net Income TTM 940.0m / Revenue TTM 5.50b)
Gross Margin = 59.95% ((Revenue TTM 5.50b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 59.31% (prev 60.11%)
Tobins Q-Ratio = 3.17 (Enterprise Value 24.39b / Total Assets 7.69b)
Interest Expense / Debt = 0.75% (Interest Expense 20.0m / Debt 2.67b)
Taxrate = 13.31% (39.0m / 293.0m)
NOPAT = 1.10b (EBIT 1.27b * (1 - 13.31%))
Current Ratio = 1.67 (Total Current Assets 3.43b / Total Current Liabilities 2.06b)
Debt / Equity = 0.86 (Debt 2.67b / totalStockholderEquity, last quarter 3.11b)
Debt / EBITDA = 0.48 (Net Debt 642.0m / EBITDA 1.35b)
Debt / FCF = 0.63 (Net Debt 642.0m / FCF TTM 1.01b)
Total Stockholder Equity = 2.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.33% (Net Income 940.0m / Total Assets 7.69b)
RoE = 34.47% (Net Income TTM 940.0m / Total Stockholder Equity 2.73b)
RoCE = 27.0% (EBIT 1.27b / Capital Employed (Equity 2.73b + L.T.Debt 1.97b))
RoIC = 20.42% (NOPAT 1.10b / Invested Capital 5.39b)
WACC = 7.61% (E(23.75b)/V(26.42b) * Re(8.39%) + D(2.67b)/V(26.42b) * Rd(0.75%) * (1-Tc(0.13)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.83%
[DCF] Terminal Value 79.58% ; FCFF base≈936.4m ; Y1≈937.2m ; Y5≈994.2m
[DCF] Fair Price = 73.79 (EV 18.93b - Net Debt 642.0m = Equity 18.29b / Shares 247.8m; r=7.61% [WACC]; 5y FCF grow -0.46% → 2.90% )
EPS Correlation: 93.89 | EPS CAGR: 11.63% | SUE: 3.79 | # QB: 2
Revenue Correlation: 95.11 | Revenue CAGR: 4.77% | SUE: -0.48 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.02 | Chg7d=+0.001 | Chg30d=-0.012 | Revisions Net=-3 | Analysts=14
EPS current Year (2026-12-31): EPS=4.19 | Chg7d=+0.007 | Chg30d=+0.013 | Revisions Net=+5 | Growth EPS=+7.5% | Growth Revenue=+6.3%
EPS next Year (2027-12-31): EPS=4.55 | Chg7d=+0.003 | Chg30d=+0.001 | Revisions Net=+3 | Growth EPS=+8.6% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -0.33 (3 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.5% (Discount Rate 8.4% - Earnings Yield 3.9%)
[Growth] Growth Spread = +1.8% (Analyst 6.3% - Implied 4.5%)